David Feifel
Professor Emeritus · University of California (San Diego) Medical Center
Credentials: · · ·
History
Research
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression
New England Journal of Medicine · 2022 · 867 citations
American Journal of Psychiatry · 2019 · 321 citations
A systematic review of modafinil: Potential clinical uses and mechanisms of action
Systematic review or meta-analysis · The Journal of Clinical Psychiatry · 2006 · 263 citations
- KM
16 papers
- AM
9 papers
- EM
6 papers
6 papers · 5 as a fellow
- AB
5 papers
- AT
5 papers
5 papers
- GV
5 papers
Grants
- 2015–2021
Oxytocin as a Therapeutic Target for Schizophrenia
National Institute of Mental Health · R01
Contact PI · $1.7M · Veterans Medical Research Fdn/San Diego
- 2009–2015
Neurotensin-1 Receptor as a Therapeutic Target for Schizophrenia
National Institute of Mental Health · R01
Contact PI · $1.9M · University of California, San Diego
- 2011–2014
1/2-Anti-Psychotic Effects of Oxytocin
National Institute of Mental Health · R34
Contact PI · $510.3K · University of California, San Diego
- 2005–2011
A Novel Animal Model of Relevance to Schizophrenia
National Institute of Mental Health · R01
Contact PI · $1.1M · University of California, San Diego
Clinical trials
- 2017–2019
Testing the Value of Smartphone Assessments of People With Mood Disorders
Principal investigator · Completed
Mindstrong
- 2011–2018
Antipsychotic Effects of Oxytocin
Principal investigator · Terminated
University of California, San Diego
- 2010–2015
- 2009–2011
Oxytocin Add-on Study for Stable Anxiety Patients
Principal investigator · Terminated
University of California, San Diego